节点文献

中国人群矽肺的疾病负担分析及预测探讨

Discussion on analysis and prediction of disease burden of silicosis in Chinese population

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 袁方孟诗迪吴梦云张华东朱晓俊

【Author】 YUAN Fang;MENG Shidi;WU Mengyun;ZHANG Huadong;ZHU Xiaojun;Department of Occupational Health and Radiological Health, Chongqing Center for Disease Control and Prevention;

【通讯作者】 朱晓俊;

【机构】 重庆市疾病预防控制中心公卫所职业与放射卫生所国家卫生健康委职业安全卫生研究中心/国家卫生健康委粉尘危害工程防护重点实验室

【摘要】 目的 对1990—2021年中国人群矽肺的疾病负担进行系统分析,并预测2022—2030年的疾病负担水平,为矽肺防治的政策制定和措施实行提供数据支持。方法 应用发病、死亡和伤残调整生命年(disability-adjusted life-years, DALYs)的绝对数、率及其年龄标准化率衡量1990—2021年我国矽肺的疾病负担;采用年均变化率(estimated annual percentage change, EAPC)反映疾病负担指标的标准化率随时间变化情况;应用贝叶斯年龄-时期-队列(Bayesian age-period-cohort, BAPC)模型预测2022—2030年中国人群矽肺疾病负担。结果 与1990年相比,2021年中国人群矽肺发病数由1.33万例(95%UI 1.10~1.58)增至2.34万例(95%UI 1.99~2.70),死亡数由0.48万例(95%UI 0.35~0.63)增至0.63万例(95%UI 0.47~0.82),DALYs由15.07万人年(95%UI 11.39~19.36)增至17.31万人年(95%UI 13.44~22.47)。2021年中国矽肺发病数、死亡数和DALYs占全球总水平的比例分别为65.92%、61.76%、66.25%,其中在55~<60岁组发病比例最高(75.94%),40~<45岁组死亡比例最高(79.52%),DALYs在40~<45岁组比例最高(75.95%)。1990—2021年,我国全人群年龄标化发病率的EAPC-0.98%(95%CI-1.11%~-0.86%);年龄标化死亡率的EAPC-2.06%(95%CI-2.16%~-1.97%);年龄标化DALY率的EAPC-2.15%(95%CI-2.22%~-2.09%)。预测结果显示,2022—2030年中国矽肺的标化发病率预计在1.80/10万上下浮动,标化死亡率从0.61/10万降至0.48/10万。结论 虽然中国矽肺疾病负担呈下降趋势,但由于其现存病例数庞大,在未来职业病防治领域仍占据重要地位。

【Abstract】 Objective Analyze the disease burden of silicosis in Chinese population from 1990 to 2021, and predict the disease burden level of 2022 to 2030, thereby provide some data support for the policy formulation and measure implementation of silicosis prevention and control in future.Methods The disease burden of silicosis in China from 1990 to 2021 was measured using the absolute number, rate, and age standardized rate of incidence, death and disability adjusted life-years(DALYs), the estimated annual percentage change(EAPC) was used to reflect the standardized rate of disease burden indicators over time, and Bayesian age-period-cohort(BAPC) model was used to predict the disease burden of silicosis in the Chinese population from 2022 to 2030.Results Compared with 1990, the number of silicosis cases in the Chinese population increased from 13 300(95%UI 11 000~15 800) to 23 400(95%UI 19 900~27 000) in 2021,the deaths number from 4 800(95%UI 3 500~6 300) increased to 6 300(95%UI 4 700~8 200),and DALYs from 150 700 person-years(95%UI 113 900~193 600) also increased to 173 100 person-years(95%UI 134 400~224 700).In 2021, the incidence, mortality and DALYs of sicosis in China accounted for 65.92%, 61.76% and 66.25% of the global total, respectively, the highest proportion of incidence was in the 55 to <60 age group(75.94%), the highest proportion of death was in the 40 to <45 age group(79.52%), and the highest proportion of DALYs was in the 40 to <45 age group(75.95%).From 1990 to 2021, the EAPC of age-standardized incidence rate(ASIR) in whole population in China was-0.98%( 95%CI-1.11%~-0.86%), the EAPC of age-standardized mortality rate(ASMR) was-2.06%(95%CI-2.16%~-1.97%), the EAPC of age-standardized DALY rate(ASDR) was-2.15%(95%CI-2.22%~-2.09%).The prediction results show that the ASIR of silicosis in China is expected to fluctuate around 1.80/100 000 from 2022 to 2030, and the ASMR will decrease from 0.61/100 000 to 0.48/100 000.Conclusion The results suggested that although the burden of silicosis in China is decreasing, due to its large number of existing cases, it still holds an important position in the field of future prevention and control of occupational disease.

【基金】 国家重点研发计划项目(2018YFC1315303);重庆市科卫联合医学科研项目(2022ZDXM034)
  • 【文献出处】 中国工业医学杂志 ,Chinese Journal of Industrial Medicine , 编辑部邮箱 ,2024年06期
  • 【分类号】R135.2
  • 【下载频次】30
节点文献中: 

本文链接的文献网络图示:

本文的引文网络